Samelson-Jones Laboratory Publications

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

7 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Below are selected publications from the Samelson-Jones Lab. See Pubmed for a full list: https://www.ncbi.nlm.nih.gov/myncbi/ben.samelson-jones.1/bibliography/public/.

Samelson-Jones BJ, Finn JD, Favaro P, Wright JF, Arruda VR. Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates. Mol Ther Methods Clin Dev. 2020 May; 17:1129-1138. PMID: 32490034
Samelson-Jones BJ, Finn JD, George LA, Camire RM, Arruda VR. Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity. JCI Insight. 2019 Jun; 5(14). PubMed PMID: 31219805
George LA, et al. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med. 2017 Dec; 377(23):2215-2227. PMID: 29211678
Siner JI, Samelson-Jones BJ, Crudele JM, French RA, Lee BJ, Zhou S, Merricks E, Raymer R, Nichols TC, Camire RM, Arruda VR. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models. JCI Insight. 2016 Oct; 1(16):e89371. PMID: 27734034
Boudreau RL, Jiang P, Gilmore BL, Spengler RM, Tirabassi R, Nelson JA, Ross CA, Xing Y, Davidson BL. Transcriptome-wide discovery of microRNA binding sites in human brain. Neuron. 2014 Jan; 81(2): 294-305. PMID: 24389009
Samelson-Jones BJ, Yeh SR. Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Biochemistry. 2006 Jul; 45(28):8527-38. PMID: 16834326